Hyperrab 300UNIT/ML 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FW8VA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,136
Award facts
- Contract value 100% obligated
- $12,136.18 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order valued at $12,136.18 by the Defense Logistics Agency (DLA) for HYPERRAB 300 Unit/mL, a rabies immunoglobulin product used for post-exposure prophylaxis. The contract, awarded on November 28, 2025, with an ultimate completion date of November 28, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor contract running through December 2026 that serves as the primary vehicle for pharmaceutical and medical supply procurement across the Defense Health System.
As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The DLA Troop Support Medical IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. This specific delivery order for rabies immunoglobulin reflects the contractor's role in ensuring availability of critical biologics and vaccines within the Defense Health System's supply chain. The contract was competitively awarded, demonstrating AmerisourceBergen's capability to meet federal procurement standards for specialized pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DR26FW8VA?
SPE2DR26FW8VA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26FW8VA worth?
The government has obligated $12,136 on SPE2DR26FW8VA.
Is contract SPE2DR26FW8VA an order under another contract?
Yes. SPE2DR26FW8VA is a delivery order under SPE2DR25D7062, an indefinite delivery contract.
Was contract SPE2DR26FW8VA competed?
The extent of competition for SPE2DR26FW8VA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award